EPIGRALBSEEpigral LtdLowNeutral
Announced Fri, 15 May · 17:53 IST

Intimation of 19th AGM to be held on 08.06.2026.

Board & Shareholder Meetings View source PDF

EPIGRAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹1223.90
prior close
₹1209.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-1.8-2.3-2.3+1.5+1.2+3.7+1.7+1.5-1.1-6.3-6.3-11.6
Up moveDown movePending
AI summary

Epigral Ltd has scheduled its 19th AGM on June 8, 2026 at 11:00 a.m. via video conferencing. The company reported FY 2025-26 revenue of ₹2,542 Cr (down 1% YoY) and EBITDA of ₹567 Cr (down 20%) due to lower realisations, weak CPVC demand, and a major maintenance shutdown. Net profit stood at ₹333 Cr. Despite the moderation, the company continued its disciplined expansion — commissioning the Chlorotoluenes value chain and progressing CPVC Resin capacity expansion (75,000 to 150,000 TPA) and ECH expansion (50,000 to 100,000 TPA). Net worth grew 17% to ₹2,221 Cr, with Net Debt/EBITDA at a comfortable 0.9x. Credit rating was maintained at CRISIL AA/Stable. The cut-off date for e-voting entitlement is June 1, 2026.

Likely market impact

The AGM primarily covers routine business approvals. The company is navigating a temporary sectoral slowdown while executing major capacity expansions aimed at doubling CPVC and ECH output. The focus remains on shifting revenue mix toward derivatives and specialty chemicals (52% of revenues), reducing chlor-alkali exposure and building long-term resilience.